Optiscan Partners with ACL to Advance Digital Pathology
Filed with ASX · · 3 pages · English
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Appendix 4E - Preliminary Final Report
- Entitlement Issue Prospectus
- Optiscan Launches Entitlement Offer to Raise $17.75m
- Optiscan Initiates Breast Cancer Study in Melbourne
- Optiscan Signs Agreement with Long Grove Pharmaceuticals
Later from Optiscan Imaging
- Optiscan Initiates Head & Neck Cancer Imaging Study
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D
- Optiscan Submits InSpecta FDA Dossier
- Optiscan Receives $1.69m R&D Tax Refund
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging